Semax and 'fried brain' claims: what the science actually says
Quick answer
Semax is a synthetic ACTH-derived peptide with documented BDNF-modulating effects in preclinical research, approved in Russia for neurological indications but not reviewed or approved by the FDA. The creator claims it corrects dopamine, serotonin, and GABA deficits underlying ADHD and produces durable cognitive changes after short-term use, none of which is supported by published randomized controlled trials in ADHD populations. Patients interested in peptide-based cognitive support should discuss options with a licensed clinician, as quality, dosing, and safety of gray-market Semax products cannot be verified.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @aubergine_avenger actually say?
The creator makes a sweeping claim: that Semax, a Russian peptide nasal spray, fixes ADHD by simultaneously correcting low dopamine, low serotonin, and low GABA, all within "20 to 30 minutes." The pitch goes further. Use it daily for a few weeks, they say, and you can "seize taking" it entirely, because the brain has been "reprogrammed" to enjoy tasks it previously hated. The changes, they claim, are permanent.
This is not a modest claim. This is a claim that a nasal spray can rewrite the neurological basis of a chronic condition and then make itself unnecessary. The creator frames this with genuine enthusiasm, calling Semax an "unbelievable compound" and a "real game changer." The disclaimer about not encouraging unapproved compounds is in the caption, not the video itself, which is doing a lot of persuasive heavy lifting in 90 seconds.
Does the science back this up?
Partially, in narrow and heavily caveated ways. The bulk of the evidence comes from Russian and Eastern European research, most of it on small samples or animal models, which matters enormously when evaluating these claims.
Semax is a synthetic heptapeptide derived from ACTH(4-7). It has been used in Russia since the 1990s as a registered nootropic and is approved there for conditions including stroke recovery and cognitive impairment. It is not approved by the FDA for any indication.
Research does show Semax influences brain-derived neurotrophic factor (BDNF) expression. A study by Dolotov et al. (2006, Journal of Neurochemistry) found intranasal Semax increased BDNF in rat hippocampal and basal forebrain regions. BDNF plays a role in neuroplasticity, which is the legitimate kernel inside the "reprogramming" framing. There is also evidence suggesting Semax modulates dopaminergic activity, though describing it as simply "fixing low dopamine" badly oversimplifies a complex receptor-level interaction. The serotonin and GABA claims are much weaker, supported mainly by indirect inference rather than direct clinical trial data in humans.
What did they get wrong (or right)?
The ADHD neuroscience in this video is reductive to the point of being misleading. The creator says ADHD means dopamine is low, serotonin is low, and GABA is low. That framing is outdated and incorrect.
- ADHD is not a simple deficiency of three neurotransmitters. The current consensus, outlined in reviews such as Faraone et al. (2021, Neuroscience and Biobehavioral Reviews), points to dysregulation of dopamine and norepinephrine signaling in prefrontal circuits, not global deficits in dopamine, serotonin, and GABA simultaneously.
- The claim that Semax can "fix" all three in 20 to 30 minutes has no peer-reviewed clinical trial support in ADHD populations. There are no published randomized controlled trials of Semax specifically for ADHD.
- The "permanent reprogramming" claim is the most irresponsible part of the video. No evidence supports the idea that short-term Semax use produces durable neurological changes that persist after stopping. BDNF upregulation in rodent studies is not evidence of permanent behavioral rewiring in humans.
What they got partially right: Semax does have a real pharmacological profile. The BDNF-related neuroplasticity angle is at least grounded in published biology, even if the conclusions drawn here go far beyond what the data supports.
What should you actually know?
Semax is not available as an FDA-approved medication in the United States. Sourcing it means buying from gray-market vendors with no regulatory quality oversight. Purity, concentration, and sterility are not guaranteed, and that matters enormously for something you are putting in your nose and absorbing nasally into your brain.
If you have ADHD and are looking at peptide-adjacent or nootropic interventions because conventional treatments have not worked, that is a legitimate frustration worth discussing with a clinician. What is not legitimate is concluding from a 90-second TikTok that a Russian peptide will permanently rewire your operating system after a few weeks of use.
Telehealth providers operating under US regulations cannot prescribe Semax. Any platform claiming otherwise should be a red flag. If you are considering any peptide therapy, the conversation starts with a licensed provider reviewing your full medical history, not a social media video.
The creator's disclaimer exists. It is not enough to offset a video that confidently attributes specific neurochemical mechanisms and permanent outcomes to an unproven compound, without a single study cited.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax and 'fried brain' claims: what the science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax and 'fried brain' claims: what the science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Semax is a synthetic ACTH-derived peptide with documented BDNF-modulating effects in preclinical research, approved in Russia for neurological indications but not reviewed or approved by the FDA.
FormBlends verdict
Semax is a synthetic ACTH-derived peptide with documented BDNF-modulating effects in preclinical research, approved in Russia for neurological indications but not reviewed or approved by the FDA. The creator claims it corrects dopamine, serotonin, and GABA deficits underlying ADHD and produces durable cognitive changes after short-term use, none of which is supported by published randomized controlled trials in ADHD populations. Patients interested in peptide-based cognitive support should discuss options with a licensed clinician, as quality, dosing, and safety of gray-market Semax products cannot be verified.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax is a synthetic ACTH-derived peptide with documented BDNF-modulating effects in preclinical research, approved in Russia for neurological indications but not reviewed or approved by the FDA. The creator claims it corrects dopamine, serotonin, and GABA deficits underlying ADHD and produces durable cognitive changes after short-term use, none of which is supported by published randomized controlled trials in ADHD populations. Patients interested in peptide-based cognitive support should discuss options with a licensed clinician, as quality, dosing, and safety of gray-market Semax products cannot be verified.
- Semax is FDA-unapproved in the US; it is a registered nootropic in Russia used since the 1990s for neurological conditions, not ADHD specifically.
- Dolotov et al. (2006, Journal of Neurochemistry) confirmed Semax raises BDNF in rodent brain regions linked to memory and learning, which is the legitimate science behind the neuroplasticity angle.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is FDA-unapproved in the US; it is a registered nootropic in Russia used since the 1990s for neurological conditions, not ADHD specifically.
- Dolotov et al. (2006, Journal of Neurochemistry) confirmed Semax raises BDNF in rodent brain regions linked to memory and learning, which is the legitimate science behind the neuroplasticity angle.
- No published randomized controlled trial has evaluated Semax for ADHD in humans, making any specific ADHD efficacy claim currently unverifiable.
- The ADHD-as-three-low-neurotransmitters model presented in the video is an oversimplification rejected by current neurobiological research, which centers on prefrontal dopamine and norepinephrine circuit dysregulation.
- Gray-market Semax products sold online carry no guaranteed purity or concentration standards, introducing real safety unknowns for nasal-to-brain delivery.
- The claim that short-term Semax use produces permanent cognitive changes after stopping has no supporting human trial data and should be treated as speculation.
- Patients with ADHD exploring alternative or adjunct therapies should work with a licensed clinician who can assess their full history, not rely on mechanism claims made in unverified social media content.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Afser Choudry · TikTok creator
26.6K views on this video
A russian peptide that fixes your fried brain? Maybe that's not asking for too much. Disclaimer: I do NOT encourage the use of steroids, research compounds or substances not approved for human use. Always consult a medical professional before considering any enhancement protocol.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Afser Choudry, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.